Group One Trading’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Group One Trading’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,399	Closed	-$187K	–	8404
2023 Q1	$155K	Buy	+5,399	New	+$160K	﹤0.01%	3899
2022 Q4	–	Sell	-13,871	Closed	-$452K	–	8360
2022 Q3	$281K	Buy	+13,871	New	+$253K	﹤0.01%	3813

Group One Trading's DICE Position: Q2 2023 in Review

Group One Trading sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q2 2023, closing a stake of 5,399 shares — an estimated $187K sold.

Group One Trading first reported a position in DICE in Q3 2022 and held it in 2 quarters. The position peaked at $281K in Q3 2022. 160 funds tracked by Wall St. Rank hold DICE as of Q2 2023.

Group One Trading reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Group One Trading sold 5,399 DICE Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $187K.
Group One Trading first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
Group One Trading's DICE Therapeutics, Inc. Common Stock position peaked at $281K in Q3 2022.
160 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.